| COVID-19 |
1 |
1 |
| Bacteria |
0 |
0.88 |
| Microbiome |
0 |
0.7 |
| COVID-19 Vaccine |
0 |
0.3 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.29 |
| Fatigue |
0 |
0.22 |
| Brain |
0 |
0.15 |
| Hair |
0 |
0.15 |
| Hospital |
0 |
0.15 |
| Anxiety |
0 |
0.07 |
| Clostridial Infection |
0 |
0.07 |
| Cough |
0 |
0.07 |
| Diversity |
0 |
0.07 |
| Fatty Acids |
0 |
0.07 |
| Immunization |
0 |
0.07 |
| Massachusetts |
0 |
0.07 |
| Memory |
0 |
0.07 |
| Microbiology |
0 |
0.07 |
| Opportunistic Infection |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Severe Acute Respiratory Syndrome |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Acute Respiratory Distress Syndrome |
0 |
0.06 |
| Anxiety Disorder |
0 |
0.06 |
| Otolaryngology |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Vaccines |
0 |
0.06 |